Nasdaq
$0.5910▲ 5.52%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $55.0MShares out 93.0M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
7- 1d agoAfter-hours26.10.24 05:108-KKey event#●●●#●●●
CITIUS ONCOLOGY, INC.
Citius Oncology has received an extension from Nasdaq until April 19, 2027, to regain compliance with the $1.00 per share minimum bid price requirement. The company must maintain a closing bid price of at least $1.00 for ten consecutive business days within this period to satisfy the listing rule and is currently evaluating options to achieve this.…more
$0.5910+5.52%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.29After-hours26.09.30 05:308-KKey event
CITIUS ONCOLOGY, INC.
Citius Oncology, Inc. held its 2026 annual meeting of stockholders on September 29, 2026, where shareholders elected three Class II directors and ratified the selection of Wolf & Company, P.C. as the independent registered public accounting firm for the fiscal year ending September 30, 2026.…more
$0.5910+5.52%vs prev closeView filingShare - 8.26Pre-market26.08.26 22:02ARSOther
CITIUS ONCOLOGY, INC.
Citius Oncology, Inc. has filed its Annual Report to Security Holders (ARS) for the fiscal year ended September 30, 2025, with the SEC. This filing provides comprehensive details on the company's financial condition and business operations, allowing investors to review the annual performance and future management strategies.…more
$0.5910+5.52%vs prev closeView filingShare
6 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswireNo news collected yet. New articles will appear here.